由于药品关税和供应链问题,保健信息技术投资转移了重点。 Healthcare IT investments shift focus due to pharmaceutical tariffs and supply chain issues.

在2025年问题3中,保健信息技术投资正在适应药品关税增加和全球供应链问题带来的新挑战。 In Q3 2025, healthcare IT investments are adapting to new challenges posed by increased pharmaceutical tariffs and global supply chain issues. 黑皮书研究的一项调查发现,92%的合并和收购顾问现在在估值中考虑关税和最惠国政策,将重点转向国内第一技术平台和灵活的交易结构,如分阶段付款和挣取收入。 A survey by Black Book Research finds that 92% of M&A advisors now consider tariffs and MFN policies in valuations, shifting focus towards domestic-first tech platforms and flexible deal structures like phased payments and earn-outs. 私募股权团体正在脱离国际供应链,以防范关税冲击和价格波动。 Private equity groups are moving away from international supply chains to protect against tariff shocks and price volatility.